Dr. Sharon Orrange - September 06, 2016
Fatty liver disease is now the most common cause of abnormal liver blood tests in the United States. Non-alcoholic fatty liver disease, or NAFLD, is often discovered during a visit to your doctor, with the news that your “liver function blood tests” are abnormal. After being told your AST and ALT blood tests are abnormal you may have a liver ultrasound to confirm fatty liver changes.
NAFLD can lead to cirrhosis—chronic liver damage, that can lead to liver failure—so here are 10 ways to reverse fatty liver. See More
Dr. Sharon Orrange - June 15, 2015
Many Americans struggle with their weight. More than two-thirds of American adults are considered overweight, and one-third are obese. Obesity-related illness is estimated to cost the American economy almost $200 billion a year.
Sadly, there isn’t yet a perfect pill to end obesity. However, there are a variety of prescription options to help you jump-start your weight loss, with a number of new drugs approved in just the past few years. See More
Dr. Sharon Orrange - December 31, 2014
Dr. Sharon Orrange - September 16, 2014
Do we have better meds for weight loss now? September brought news of two new weight loss medications, Contrave and Saxenda. Funny thing is both of them are drugs used for other indications, now approved for weight loss. So these meds have been around, in one form or another. These two will join Belviq, Qsymia, and orlistat (available over the counter as Alli).
Roni Shye - April 10, 2014
Recently, you may have noticed several medications available in the store aisles that used to require a prescription. A few drugs have made the jump from prescription-only to being sold over-the-counter (OTC) without a prescription, with Nexium as the newest (and a very exciting) example.
The status change for Nexium 20 mg capsules was approved by the FDA on March 28th, 2014. Nexium is used mainly for the treatment of gastrointestinal esophageal reflux disease (GERD), better known as acid reflux or heartburn. See More
Elizabeth Davis - March 28, 2014
Manufacturer GlaxoSmithKline has voluntarily issued a recall for all of its non-prescription Alli weight loss products in the United States and Puerto Rico. The recall is due to concerns that the product packages may have been tampered with, and do not actually contain Alli.